BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17041637)

  • 1. Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia.
    Boag JM; Beesley AH; Firth MJ; Freitas JR; Ford J; Hoffmann K; Cummings AJ; de Klerk NH; Kees UR
    Leukemia; 2006 Oct; 20(10):1731-7. PubMed ID: 17041637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.
    Jumaa H; Bossaller L; Portugal K; Storch B; Lotz M; Flemming A; Schrappe M; Postila V; Riikonen P; Pelkonen J; Niemeyer CM; Reth M
    Nature; 2003 May; 423(6938):452-6. PubMed ID: 12761551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.
    Ma H; Qazi S; Ozer Z; Gaynon P; Reaman GH; Uckun FM
    Br J Haematol; 2012 Jan; 156(1):89-98. PubMed ID: 22017452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
    Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
    Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of an abnormal sized c-kit transcript in Hong Kong Chinese acute lymphoblastic leukaemia patients.
    Chui CH; Lau FY; Chan AH; Tang JC; Hui CH; Lam CC; Chan LC; Cheng G
    Clin Lab Haematol; 1996 Dec; 18(4):261-3. PubMed ID: 9054699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia.
    Todisco E; Gaipa G; Biagi E; Bonamino M; Gramigna R; Introna M; Biondi A
    Leukemia; 2002 Oct; 16(10):2046-54. PubMed ID: 12357356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
    Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
    Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZAP-70 is highly expressed in most cases of childhood pre-B cell acute lymphoblastic leukemia.
    Wandroo F; Bell A; Darbyshire P; Pratt G; Stankovic T; Gordon J; Lawson S; Moss P
    Int J Lab Hematol; 2008 Apr; 30(2):149-57. PubMed ID: 18333847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
    Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
    Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P--a potent risk factor in childhood lymphoblastic leukaemia.
    Nowicki M; Miśkowiak B
    Leukemia; 2003 Jun; 17(6):1096-9. PubMed ID: 12764374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH-CCS-PCR.
    Qiu J; Gunaratne P; Peterson LE; Khurana D; Walsham N; Loulseged H; Karni RJ; Roussel E; Gibbs RA; Margolin JF; Gingras MC
    Leukemia; 2003 Sep; 17(9):1891-900. PubMed ID: 12970791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells.
    Kominsky DJ; Klawitter J; Brown JL; Boros LG; Melo JV; Eckhardt SG; Serkova NJ
    Clin Cancer Res; 2009 May; 15(10):3442-50. PubMed ID: 19401345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7.
    Renard N; Duvert V; Matthews DJ; Pagés MP; Magaud JP; Manel AM; Pandrau-Garcia D; Philippe N; Banchereau J; Saeland S
    Leukemia; 1995 Jul; 9(7):1219-26. PubMed ID: 7630198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.
    Talby L; Chambost H; Roubaud MC; N'Guyen C; Milili M; Loriod B; Fossat C; Picard C; Gabert J; Chiappetta P; Michel G; Schiff C
    Leuk Res; 2006 Jun; 30(6):665-76. PubMed ID: 16297978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
    Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In childhood acute lymphoblastic leukemia the hypophosphorylated retinoblastoma protein, p110RB, is diminished, as compared with normal CD34+ peripheral blood progenitor cells.
    Leibundgut K; Schmitz N; Tobler A; Lüthy AR; Hirt A
    Pediatr Res; 1999 May; 45(5 Pt 1):692-6. PubMed ID: 10231867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
    Rhein P; Scheid S; Ratei R; Hagemeier C; Seeger K; Kirschner-Schwabe R; Moericke A; Schrappe M; Spang R; Ludwig WD; Karawajew L
    Leukemia; 2007 May; 21(5):897-905. PubMed ID: 17330098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.